ELUTIA INC.

Develops drug-eluting biologics to reduce complications from medical implants.

ELUT | US

Overview

Corporate Details

ISIN(s):: US05479K1060
LEI:
Country:: United States of America
Address:: 12510 PROSPERITY DRIVE, 20904 SILVER SPRING
Website:: https://elutia.com/
Sector:: Manufacturing
Industry:: Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Elutia Inc. is a commercial-stage company that develops and commercializes drug-eluting biologic products to improve compatibility between medical devices and patients. The company's proprietary drug-eluting biomaterial platforms combine natural biologic materials with extended-release antibiotics to address post-surgical complications from implant failures. Its key offerings include CanGaroo, an acellular device envelope for implantable electronics like pacemakers and neurostimulators, and SimpliDerm, a human acellular dermal matrix for soft tissue reconstruction. These products are designed to mitigate fibrotic responses, ensure implant stability, and support wound healing. Formerly known as Aziyo Biologics, the company rebranded to Elutia to reflect its strategic focus on drug-eluting biomatrices.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Quick Filters:

Filters

Filing Type

Language

Start date

End date

Clear

Bulk Actions:

	Date	Filing	Language	Size	Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all ELUTIA INC. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for ELUTIA INC.

This data is available as part of our premium data solutions. Contact our team for access.

Request This Data

Need More History? Access decades of standardized financials for ELUTIA INC. via our API.

Get Historical Data →

Insider Transactions

Date	Insider Name	Position	Type	Shares	Value
No insider transactions recorded for this company.

Peer Companies

Company	Country	Ticker
Immix Biopharma, Inc. Developing safer cell therapies for AL Amyloidosis and hematologic malignancies.	United States of America	IMMX
IMMUCELL CORP /DE/ Develops biotech health products for disease prevention in dairy and beef cattle.	United States of America	ICCC
Immuneering Corp Clinical-stage oncology firm using bioinformatics to develop oral MEK inhibitors for solid tumors.	United States of America	IMRX
ImmuneOncia Therapeutics, Inc. A biopharma firm developing immune checkpoint inhibitors for cancer immunotherapy.	South Korea	424870
ImmunityBio, Inc. Develops immunotherapies activating the immune system to fight cancer and infectious diseases.	United States of America	IBRX
Immuno-Biological Laboratories Co., Ltd. Develops and supplies immunological reagents and diagnostics for research and drug discovery.	Japan	4570
Immunocore Holdings plc Pioneering TCR bispecific immunotherapies for cancer, infectious, and autoimmune diseases.	United States of America	IMCR
Immunome Inc. Develops targeted oncology therapies, like ADCs, for cancers with high unmet needs.	United States of America	IMNM
Immunovant, Inc. Developing novel, FcRn-targeted therapies for people with autoimmune diseases.	United States of America	IMVT
Immuron Ltd Develops oral antibodies from bovine colostrum for digestive and immune health.	United States of America	IMRN